Hide

FocusBar

FeedbackFeedback
Subscribe to Premium Member
5.39 (1y: -42%)
Market Cap 696.59 M P/E(ttm)
Enterprise Value 491.29 M P/B 3.30
IDIX- NAS (USA)
Idenix Pharmaceuticals, Inc.
  • Currently 1/5
Business Predictability Rank: 1-Star
Back Testing Results:
Average gain of all 1-Star stocks: 1.1% per year.
% of Stocks that are in still loss if held for 10yrs: 45%.
Read more:
What is Predictability Rank?
Performances of real portfolio
Top Ranked Predictable Companies
$5.39
Switch to:
Jump to: Guru Trade | Guru Ownership | Insider Trade

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M697Revenue $M34.9Net Margin (%)-46.5Z-Score6.5
Enterprise Value $M491EPS $-0.6Operating Margin %-50.8F-Score2
P/E(ttm))0Cash Flow Per Share $-0.5Pre-tax Margin (%)-46.6Higher ROA y-yN
Price/Book3.310-y EBITDA Growth Rate %-6.6Quick Ratio2.5Cash flow > EarningsN
Price/Sales19.45-y EBITDA Growth Rate %-28.7Current Ratio17.5Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-12.9Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-14.8Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M134ROI % (ttm)-24.7Gross Margin Increase y-yY

Gurus Latest Trades with IDIX

Please Subscribe to see portfolio changes after the end of the last quarter. Real Time Picks are included for Premium Members only! Plans start from as little as $299/year.

7-Day FREE TRIAL
Select Gurus | Default List of Gurus | All Investors | Mutual Fund Gurus | Hedge Fund Gurus
Number of guru portfolios checked: 51.
Total Records: 22   Page:1 2 Next Page
TickerGuruDate Action
 Impactdown Price Range
(Average)* 		Current Price Change from Average Comment Current Shares
IDIXSeth Klarman 2013-03-31 Add0.61%$3.54 - $5.36
($4.6)		 $ 5.3917%Add 25.78%26,042,000
IDIXJohn Burbank 2013-03-31 Sold Out -0.19%$3.54 - $5.36
($4.6)		 $ 5.3917%Sold Out0
IDIXSeth Klarman 2012-12-31 Add1.35%$3.52 - $5.3
($4.51)		 $ 5.3920%Add 72.54%20,704,700
IDIXJean-Marie Eveillard 2012-12-31 Sold Out -0.0025%$3.52 - $5.3
($4.51)		 $ 5.3920%Sold Out0
IDIXSeth Klarman 2012-09-30 Add0.28%$4.39 - $11.06
($7.89)		 $ 5.39-32%Add 20%12,000,000
IDIXJean-Marie Eveillard 2012-09-30 Buy $4.39 - $11.06
($7.89)		 $ 5.39-32%New holding, 150000 sh.150,000
IDIXSeth Klarman 2012-06-30 Add0.47%$7.24 - $10.71
($8.92)		 $ 5.39-40%Add 21.23%10,000,000
IDIXJohn Burbank 2012-06-30 Add0.26%$7.24 - $10.71
($8.92)		 $ 5.39-40%Add 150%1,250,000
IDIXSeth Klarman 2012-03-31 Add0.85%$7.01 - $14.89
($11.02)		 $ 5.39-51%Add 45.61%8,249,000
IDIXJohn Burbank 2012-03-31 Buy 0.17%$7.01 - $14.89
($11.02)		 $ 5.39-51%New holding, 500000 sh.500,000
IDIXGeorge Soros 2012-03-31 Sold Out -0.08%$7.01 - $14.89
($11.02)		 $ 5.39-51%Sold Out0
IDIXSeth Klarman 2011-12-31 Add0.73%$4.55 - $8.22
($6.49)		 $ 5.39-17%Add 126.6%5,665,000
IDIXGeorge Soros 2011-12-31 Add0.08%$4.55 - $8.22
($6.49)		 $ 5.39-17%Add 1382.72%255,028
IDIXSeth Klarman 2011-09-30 Add0.21%$4.15 - $6.96
($5.68)		 $ 5.39-5%Add 99.09%2,500,000
IDIXGeorge Soros 2011-09-30 Buy $4.15 - $6.96
($5.68)		 $ 5.39-5%New holding, 17200 sh.17,200
IDIXSeth Klarman 2011-06-30 Buy 0.26%$2.9 - $5.3
($4.65)		 $ 5.3916%New holding, 1255700 sh.1,255,700
IDIXJean-Marie Eveillard 2010-03-31 Sold Out -0.01%$2.12 - $3.06
($2.78)		 $ 5.3994%Sold Out0
IDIXJean-Marie Eveillard 2009-09-30 Add$2.79 - $4.99
($3.34)		 $ 5.3961%Add 72.54%333,000
IDIXJean-Marie Eveillard 2008-03-31 Sold Out -0.01%$2.64 - $5.56
($4.8)		 $ 5.3912%Sold Out0
IDIXJean-Marie Eveillard 2007-09-30 Add$2.62 - $5.85
($3.2)		 $ 5.3968%Add 80.18%561,800
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.
Total Records: 22   Page:1 2 Next Page

IDIX is held by these Gurus:

Select Gurus | Default List of Gurus | All Investors | Mutual Fund Gurus | Hedge Fund Gurus
Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
IDIX Seth Klarman 2013-03-3126,042,00019.443+25.78%
IDIX John Burbank 2013-03-31000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


IDIX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Fanning PaulSVP, Human Resources 2012-03-16Sell30,000$11.04-51.18view
NOVARTIS AG 2011-02-25Buy3,723$3.7145.28view
NOVARTIS AG 2010-11-26Buy1,983$5.095.89view
NOVARTIS AG 2010-08-13Buy37,214$2.45120view
HODGSON THOMAS RDirector 2009-12-16Buy25,387$2.14151.87view
HODGSON THOMAS RDirector 2009-12-14Buy24,613$2.09157.89view
Weidenbruch JohnEx. VP, Gen. Counsel and Secr. 2009-11-24Buy20,000$1.89185.19view
NOVARTIS AG10% Owner 2006-06-06Buy365$20.48-73.68view
NOVARTIS AG10% Owner 2006-04-04Buy2,938$16.23-66.79view
NOVARTIS AG10% Owner 2005-10-31Buy3,939,131$20.61-73.85view

Press Releases about IDIX :

Quarterly/Annual Reports about IDIX:

    News about IDIX:

    Articles On GuruFocus.com
    Seth Klarman Buys BP, AIG, Elan Corp, Sells News Corp., Oracle May 14 2013 
    valuation May 12 2013 
    The Far-Off Four, 52-week Lows Held by Gurus May 11 2013 
    Numbers for the Day May 08 2013 
    IDIX at 52-Week Low - Gurus Cohen, Klarman Holding On Apr 03 2013 
    Seth Klarman - IDIX Mega Shares and New FDA 'Breakthrough' Track Mar 29 2013 
    comment on IDIX Mar 18 2013 
    Seth Klarman Q4/12 Mar 17 2013 
    Seth Klarman Buys Rovi Corp, Novagold, Idenix Pharmaceuticals, Sells Hewlett-packard, Microsoft and Nov 13 2012 
    The Baupost Group’s Seth Klarman Adds to Stake of Idenix Pharmaceuticals Nov 13 2012 

    Add Notes, Comments or Ask Questions

    Please log in first

    Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK